[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

United States Cancer Diagnostics Market Report 2017

December 2017 | 97 pages | ID: U5E5FA044C1EN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the United States Cancer Diagnostics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
  • The West
  • Southwest
  • The Middle Atlantic
  • New England
  • The South
  • The Midwest
  • with sales (volume), revenue (value), market share and growth rate of Cancer Diagnostics in these regions, from 2012 to 2022 (forecast).
United States Cancer Diagnostics market competition by top manufacturers/players, with Cancer Diagnostics sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • C.R. Bard, Inc.
  • GE Healthcare
  • Becton, Dickinson and Company
  • Abbott
  • Roche
  • Thermo Fisher Scientific
  • Agilent Technologies
  • Siemens Healthcare
  • Illumina
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • Diagnostic Reagent
  • Diagnostic Instrument
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Breast Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Melanoma
  • Other Cancers
If you have any special requirements, please let us know and we will offer you the report as you want.
United States Cancer Diagnostics Market Report 2017

1 CANCER DIAGNOSTICS OVERVIEW

1.1 Product Overview and Scope of Cancer Diagnostics
1.2 Classification of Cancer Diagnostics by Product Category
  1.2.1 United States Cancer Diagnostics Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Cancer Diagnostics Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Diagnostic Reagent
  1.2.4 Diagnostic Instrument
1.3 United States Cancer Diagnostics Market by Application/End Users
  1.3.1 United States Cancer Diagnostics Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Breast Cancer
  1.3.3 Lung Cancer
  1.3.4 Colorectal Cancer
  1.3.5 Melanoma
  1.3.6 Other Cancers
1.4 United States Cancer Diagnostics Market by Region
  1.4.1 United States Cancer Diagnostics Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Cancer Diagnostics Status and Prospect (2012-2022)
  1.4.3 Southwest Cancer Diagnostics Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Cancer Diagnostics Status and Prospect (2012-2022)
  1.4.5 New England Cancer Diagnostics Status and Prospect (2012-2022)
  1.4.6 The South Cancer Diagnostics Status and Prospect (2012-2022)
  1.4.7 The Midwest Cancer Diagnostics Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Cancer Diagnostics (2012-2022)
  1.5.1 United States Cancer Diagnostics Sales and Growth Rate (2012-2022)
  1.5.2 United States Cancer Diagnostics Revenue and Growth Rate (2012-2022)

2 UNITED STATES CANCER DIAGNOSTICS MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Cancer Diagnostics Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Cancer Diagnostics Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Cancer Diagnostics Average Price by Players/Suppliers (2012-2017)
2.4 United States Cancer Diagnostics Market Competitive Situation and Trends
  2.4.1 United States Cancer Diagnostics Market Concentration Rate
  2.4.2 United States Cancer Diagnostics Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Cancer Diagnostics Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES CANCER DIAGNOSTICS SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Cancer Diagnostics Sales and Market Share by Region (2012-2017)
3.2 United States Cancer Diagnostics Revenue and Market Share by Region (2012-2017)
3.3 United States Cancer Diagnostics Price by Region (2012-2017)

4 UNITED STATES CANCER DIAGNOSTICS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Cancer Diagnostics Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Cancer Diagnostics Revenue and Market Share by Type (2012-2017)
4.3 United States Cancer Diagnostics Price by Type (2012-2017)
4.4 United States Cancer Diagnostics Sales Growth Rate by Type (2012-2017)

5 UNITED STATES CANCER DIAGNOSTICS SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Cancer Diagnostics Sales and Market Share by Application (2012-2017)
5.2 United States Cancer Diagnostics Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES CANCER DIAGNOSTICS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 C.R. Bard, Inc.
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Cancer Diagnostics Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 C.R. Bard, Inc. Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 GE Healthcare
  6.2.2 Cancer Diagnostics Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 GE Healthcare Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Becton, Dickinson and Company
  6.3.2 Cancer Diagnostics Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Becton, Dickinson and Company Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Abbott
  6.4.2 Cancer Diagnostics Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Abbott Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Roche
  6.5.2 Cancer Diagnostics Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Roche Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Thermo Fisher Scientific
  6.6.2 Cancer Diagnostics Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Thermo Fisher Scientific Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Agilent Technologies
  6.7.2 Cancer Diagnostics Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Agilent Technologies Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Siemens Healthcare
  6.8.2 Cancer Diagnostics Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Siemens Healthcare Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Illumina
  6.9.2 Cancer Diagnostics Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Illumina Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview

7 CANCER DIAGNOSTICS MANUFACTURING COST ANALYSIS

7.1 Cancer Diagnostics Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Cancer Diagnostics

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Cancer Diagnostics Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Cancer Diagnostics Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES CANCER DIAGNOSTICS MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Cancer Diagnostics Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Cancer Diagnostics Sales Volume Forecast by Type (2017-2022)
11.3 United States Cancer Diagnostics Sales Volume Forecast by Application (2017-2022)
11.4 United States Cancer Diagnostics Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of Cancer Diagnostics
Figure United States Cancer Diagnostics Market Size (K Units) by Type (2012-2022)
Figure United States Cancer Diagnostics Sales Volume Market Share by Type (Product Category) in 2016
Figure Diagnostic Reagent Product Picture
Figure Diagnostic Instrument Product Picture
Figure United States Cancer Diagnostics Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Cancer Diagnostics by Application in 2016
Figure Breast Cancer Examples
Table Key Downstream Customer in Breast Cancer
Figure Lung Cancer Examples
Table Key Downstream Customer in Lung Cancer
Figure Colorectal Cancer Examples
Table Key Downstream Customer in Colorectal Cancer
Figure Melanoma Examples
Table Key Downstream Customer in Melanoma
Figure Other Cancers Examples
Table Key Downstream Customer in Other Cancers
Figure United States Cancer Diagnostics Market Size (Million USD) by Region (2012-2022)
Figure The West Cancer Diagnostics Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Cancer Diagnostics Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Cancer Diagnostics Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Cancer Diagnostics Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Cancer Diagnostics Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Cancer Diagnostics Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Cancer Diagnostics Sales (K Units) and Growth Rate (2012-2022)
Figure United States Cancer Diagnostics Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Cancer Diagnostics Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Cancer Diagnostics Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Cancer Diagnostics Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Cancer Diagnostics Sales Share by Players/Suppliers
Figure 2017 United States Cancer Diagnostics Sales Share by Players/Suppliers
Figure United States Cancer Diagnostics Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Cancer Diagnostics Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Cancer Diagnostics Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Cancer Diagnostics Revenue Share by Players/Suppliers
Figure 2017 United States Cancer Diagnostics Revenue Share by Players/Suppliers
Table United States Market Cancer Diagnostics Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Cancer Diagnostics Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Cancer Diagnostics Market Share of Top 3 Players/Suppliers
Figure United States Cancer Diagnostics Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Cancer Diagnostics Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Cancer Diagnostics Product Category
Table United States Cancer Diagnostics Sales (K Units) by Region (2012-2017)
Table United States Cancer Diagnostics Sales Share by Region (2012-2017)
Figure United States Cancer Diagnostics Sales Share by Region (2012-2017)
Figure United States Cancer Diagnostics Sales Market Share by Region in 2016
Table United States Cancer Diagnostics Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Cancer Diagnostics Revenue Share by Region (2012-2017)
Figure United States Cancer Diagnostics Revenue Market Share by Region (2012-2017)
Figure United States Cancer Diagnostics Revenue Market Share by Region in 2016
Table United States Cancer Diagnostics Price (USD/Unit) by Region (2012-2017)
Table United States Cancer Diagnostics Sales (K Units) by Type (2012-2017)
Table United States Cancer Diagnostics Sales Share by Type (2012-2017)
Figure United States Cancer Diagnostics Sales Share by Type (2012-2017)
Figure United States Cancer Diagnostics Sales Market Share by Type in 2016
Table United States Cancer Diagnostics Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Cancer Diagnostics Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Cancer Diagnostics by Type (2012-2017)
Figure Revenue Market Share of Cancer Diagnostics by Type in 2016
Table United States Cancer Diagnostics Price (USD/Unit) by Types (2012-2017)
Figure United States Cancer Diagnostics Sales Growth Rate by Type (2012-2017)
Table United States Cancer Diagnostics Sales (K Units) by Application (2012-2017)
Table United States Cancer Diagnostics Sales Market Share by Application (2012-2017)
Figure United States Cancer Diagnostics Sales Market Share by Application (2012-2017)
Figure United States Cancer Diagnostics Sales Market Share by Application in 2016
Table United States Cancer Diagnostics Sales Growth Rate by Application (2012-2017)
Figure United States Cancer Diagnostics Sales Growth Rate by Application (2012-2017)
Table C.R. Bard, Inc. Basic Information List
Table C.R. Bard, Inc. Cancer Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure C.R. Bard, Inc. Cancer Diagnostics Sales Growth Rate (2012-2017)
Figure C.R. Bard, Inc. Cancer Diagnostics Sales Market Share in United States (2012-2017)
Figure C.R. Bard, Inc. Cancer Diagnostics Revenue Market Share in United States (2012-2017)
Table GE Healthcare Basic Information List
Table GE Healthcare Cancer Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure GE Healthcare Cancer Diagnostics Sales Growth Rate (2012-2017)
Figure GE Healthcare Cancer Diagnostics Sales Market Share in United States (2012-2017)
Figure GE Healthcare Cancer Diagnostics Revenue Market Share in United States (2012-2017)
Table Becton, Dickinson and Company Basic Information List
Table Becton, Dickinson and Company Cancer Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Becton, Dickinson and Company Cancer Diagnostics Sales Growth Rate (2012-2017)
Figure Becton, Dickinson and Company Cancer Diagnostics Sales Market Share in United States (2012-2017)
Figure Becton, Dickinson and Company Cancer Diagnostics Revenue Market Share in United States (2012-2017)
Table Abbott Basic Information List
Table Abbott Cancer Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Abbott Cancer Diagnostics Sales Growth Rate (2012-2017)
Figure Abbott Cancer Diagnostics Sales Market Share in United States (2012-2017)
Figure Abbott Cancer Diagnostics Revenue Market Share in United States (2012-2017)
Table Roche Basic Information List
Table Roche Cancer Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Roche Cancer Diagnostics Sales Growth Rate (2012-2017)
Figure Roche Cancer Diagnostics Sales Market Share in United States (2012-2017)
Figure Roche Cancer Diagnostics Revenue Market Share in United States (2012-2017)
Table Thermo Fisher Scientific Basic Information List
Table Thermo Fisher Scientific Cancer Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Thermo Fisher Scientific Cancer Diagnostics Sales Growth Rate (2012-2017)
Figure Thermo Fisher Scientific Cancer Diagnostics Sales Market Share in United States (2012-2017)
Figure Thermo Fisher Scientific Cancer Diagnostics Revenue Market Share in United States (2012-2017)
Table Agilent Technologies Basic Information List
Table Agilent Technologies Cancer Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Agilent Technologies Cancer Diagnostics Sales Growth Rate (2012-2017)
Figure Agilent Technologies Cancer Diagnostics Sales Market Share in United States (2012-2017)
Figure Agilent Technologies Cancer Diagnostics Revenue Market Share in United States (2012-2017)
Table Siemens Healthcare Basic Information List
Table Siemens Healthcare Cancer Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Siemens Healthcare Cancer Diagnostics Sales Growth Rate (2012-2017)
Figure Siemens Healthcare Cancer Diagnostics Sales Market Share in United States (2012-2017)
Figure Siemens Healthcare Cancer Diagnostics Revenue Market Share in United States (2012-2017)
Table Illumina Basic Information List
Table Illumina Cancer Diagnostics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Illumina Cancer Diagnostics Sales Growth Rate (2012-2017)
Figure Illumina Cancer Diagnostics Sales Market Share in United States (2012-2017)
Figure Illumina Cancer Diagnostics Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Cancer Diagnostics
Figure Manufacturing Process Analysis of Cancer Diagnostics
Figure Cancer Diagnostics Industrial Chain Analysis
Table Raw Materials Sources of Cancer Diagnostics Major Players/Suppliers in 2016
Table Major Buyers of Cancer Diagnostics
Table Distributors/Traders List
Figure United States Cancer Diagnostics Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Cancer Diagnostics Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Cancer Diagnostics Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Cancer Diagnostics Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Cancer Diagnostics Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Cancer Diagnostics Sales Volume (K Units) Forecast by Type in 2022
Table United States Cancer Diagnostics Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Cancer Diagnostics Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Cancer Diagnostics Sales Volume (K Units) Forecast by Application in 2022
Table United States Cancer Diagnostics Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Cancer Diagnostics Sales Volume Share Forecast by Region (2017-2022)
Figure United States Cancer Diagnostics Sales Volume Share Forecast by Region (2017-2022)
Figure United States Cancer Diagnostics Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories